On Apr. 14, 2020, CHF Solutions announced that physicians on the frontlines of treating patients with COVID-19 have…
On Apr. 14, 2020, Meridian Bioscience announced it had launched a series of recombinant antigens for high sensitivity…
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
On Apr. 13, 2020, Emory University developed a sensitive and specific diagnostic antibody, also known as serological tests,…
On Apr. 13, 2020, Athersys announced the FDA has authorized the Company to initiate a Phase 2/3 pivotal…
On Apr. 13, 2020, Aegis Sciences announced serving as a regional reference laboratory for COVID-19 testing being directed…
On Apr. 13, 2020, in the largest study to date of proteins related to Alzheimerﾒs disease, a team…
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
On Apr. 10, 2020, the FDA approved AstraZeneca ‘s Koselugo (selumetinib) for treatment of pediatric patients, 2 years…
On Apr. 10, 2020, STERIS announced that the FDA issued an Emergency Use Authorization (EUA) for respirator decontamination….
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
On Apr. 10, 2020, Terumo BCT and Marker Therapeutics announced the FDA issued an Emergency Use Authorization (EUA)…
On Apr. 10, 2020, Eli Lilly announced it had entered into an agreement with the National Institute of…
On Apr. 9, 2020, Chembio Diagnostics has been selected for use in a Stony Brook Medicine effort to…
On Apr. 9, 2020, Dr. Carl Wesolowski at the University of Saskatchewan discovered that metformin, often used to…
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
On Apr. 8, 2020, PharmaCyte Biotech announced a license agreement with Hai Kang Life Corp. whereby PharmaCyte received…
On Apr. 8, 2020, Vanda Pharmaceuticals and the University of Illinois at Chicago (UIC) announced a research partnership…
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
On Apr. 8, 2020, Bellerophon Therapeutics announced submission of an Investigational New Drug (IND) application to the FDA…
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIﾮ (encorafenib) in combination with cetuximab (marketed…
On Apr. 8, 2020, Chembio Diagnostics announced a second $1.5 million purchase order from UNICEF for multiplex Zika,…
On Apr. 8, 2020, CSL Behring and SAB Biotherapeutics announced a partnership to combat the coronavirus pandemic with…
On Apr. 8, 2020, NIH scientists and collaborators report that autoimmunity, a condition in which the bodyﾒs immune…
On Apr. 8, 2020, Philips announced that the U.S. Government and Philips agreed to team up to increase…
On Apr. 8, 2020, Abbott announced that the FreeStyle Libre 14 day system, a continuous glucose monitoring (CGM)…
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…